Stephan Schmidt. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » 4-Aminopyridine/therapeutic useAdultDysarthria/drug therapyDysarthria/etiologyFemaleHumansMaleMiddle AgedMultiple Sclerosis, Chronic Progressive/complicationsMultiple Sclerosis, Chronic Progressive/drug therapyPotassium Channel Blockers/therapeutic use
Substances: See more » Potassium Channel Blockers4-Aminopyridine
Year: 2012 PMID: 22936332 DOI: 10.1177/1352458512458554
Source DB: PubMed Journal: Mult Scler ISSN: 1352-4585 Impact factor: 6.312